KANIKA BHANSALI: Open Payments
NPI 1528602760 · AUSTIN, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,482 in 67 payments from 20 companies in 2025. Trend: 2023 $0 · 2024 $407 · 2025 $1,482
Food & beverage: $1,482
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 12 | $360 |
| Novo Nordisk Inc | 11 | $260 |
| ABBVIE INC. | 10 | $169 |
| AstraZeneca Pharmaceuticals LP | 5 | $102 |
| PFIZER INC. | 4 | $82 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $60 |
| Lilly USA, LLC | 3 | $56 |
| ViiV Healthcare Company | 2 | $49 |
| Dexcom, Inc. | 2 | $45 |
| GlaxoSmithKline, LLC. | 2 | $44 |
Products named: REXULTI, Wegovy, JARDIANCE, NURTEC ODT, AIRSUPRA, QULIPTA, VRAYLAR, APRETUDE.
Industry payments across TX — which companies pay providers there.
